HENDERSON, Nev., July 8, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces it has demonstrated quantification of ...
Opportunities center on digitally connected, lab-grade lateral flow tests for decentralized care, particularly infectious ...
Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...
Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.
Intelligent Bio Solutions expects a sixth U.S. patent for its innovative non-invasive drug testing technology, enhancing market entry plans. Intelligent Bio Solutions Inc. (INBS), a medical technology ...
Lateral flow immunoassays (LFIAs) represent a class of paper-based diagnostic devices designed for rapid, on-site detection of specific biomarkers in complex samples. At their core, these assays rely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results